Clinical Features and Outcomes of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid (DPP4i-Associated BP) in Thai Patients

Table 1

Summary of clinical characteristics and outcomes in our case series of DPP4i-associated bullous pemphigoid.

Case no.	Age/sex	Type of DPP4i	Latency period (months)	Dechallenge	Final outcomes
1	87/M	Linagliptin	40	No	Died from CA lung
2	74/M	Vildagliptin	128	Yes, after the onset of BP 8 months	Stable with oral prednisolone 5 mg/day
3	85/M	Vildagliptin	64	Yes, after the onset of BP 24 months	Complete remission for 5 months, and then, he died from sudden cardiac arrest
4	84/M	Sitagliptin	65	Yes, after the onset of BP 15 months	Complete remission for 4 months, and then, relapsed
5	72/M	Vildagliptin	20	Yes, after the onset of BP 2 months	BP gradually progressed, and then, he died from sudden cardiac arrest